Agres/disagree on nnz Tony.
If Trof fails the P3, then nnz value is problematic.
If Trof passes P3, then nnz value is suddenly enormous (for me and my investing dollar). Far better pre-clinical than Trof, but same basic mechanism.
This is not just about Rett's, Fragile-X and the current nnz investigations, but potentially the whole autism spectrum.
Just need the Rett's P3 to come up trumps and our (reasonable speculative) potential becomes, I repeat,, enormous.
[At face value I find our current SP almost incomprehensible. My long held explanation is that it is due to price suppression facilitated by ill-liquidity (?) in our Aussie market. If that viewpoint is naively incorrect, then I can only conclude that good judges suspect that P3 success is not the high chance that most of us here are confident of, or that the general market doesn't know opportunity when it comes knocking.]
Share Price, page-177
-
- There are more pages in this discussion • 10,536 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.91 |
Change
-0.030(0.15%) |
Mkt cap ! $2.544B | |||
| Open | High | Low | Value | Volume |
| $19.95 | $20.00 | $19.50 | $8.294M | 417.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 443 | $19.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.91 | 917 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |